Lyra Therapeutics (NASDAQ:LYRA) reported its Q1 earnings results on Friday, May 12, 2023 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Lyra Therapeutics missed estimated earnings by 22.22%, reporting an EPS of $-0.44 versus an estimate of $-0.36.
Revenue was down $4.96 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.09 which was followed by a 2.46% increase in the share price the next day.
Here's a look at Lyra Therapeutics's past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.41 | -0.44 | -0.37 | -0.91 |
| EPS Actual | -0.32 | -0.40 | -0.43 | -0.54 |
| Revenue Estimate | 150K | 140K | 1.44M | 1.25M |
| Revenue Actual | 11K | 359K | 407K | 5.37M |
To track all earnings releases for Lyra Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
